Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

Is Technology Harming Your Brain?

Is technology harming your brain? Saycomms healthcare PR team confronts different opinions on how technology affects memories and attention span.

Say Communications

Machine-made humans: a spooky prospect

The healthcare team at Saycomms PR asks if major advances in 3D printing and bioprinting could lead to machine-made humans.

Say Communications

Gilead Sciences

Gilead reports positive data on ‘universal’ hepatitis C regimen

Sets sights on regulatory approval for combination therapy 

- PMLiVE

Bio investors react as Clinton tweet pledges pricing crackdown

Pharma companies come under scrutiny for pricing policies

- PMLiVE

Amgen granted priority review for extended use of Kyprolis

Trial data shows myeloma drug's improvement over Velcade

Shire Basingstoke

Shire wins EU approval for prolonged-release ADHD drug

First treatment in its class to be licensed for ADHD in Europe

- PMLiVE

Merck prepares filings for Clostridium antibody

Moves bezlotoxumab closer into position for regulatory approval

Allergan logo

Allergan and Gedeon finally get antipsychotic green light

Antipsychotic drug Vryalar launches into increasingly competitive market

Bristol-Myers Squibb (BMS) building

Opdivo a breakthrough in kidney cancer, says FDA

BMSmoves closer to US approval of its checkpoint inhibitor cancer immunotherapy

- PMLiVE

Jardiance survival data wows diabetes conference

BoehringerIngelheim and Eli Lilly release top-line findings from landmark trial at EASD

- PMLiVE

Yolo Communications forms social media partnership

Will work with Bakamo.Social on uncovering insightsfrom conversations

- PMLiVE

Counting down to the EFPIA Disclosure Code

Communications director Andy Powrie-Smith on why the Code is part of pharma's 'licence to operate'

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links